4.7 Editorial Material

Immunotherapy in Patients With Locally Advanced Esophageal Carcinoma: ASCO Treatment of Locally Advanced Esophageal Carcinoma Guideline Rapid Recommendation Update

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Ronan J. Kelly et al.

Summary: In patients with resected esophageal or gastroesophageal junction cancer who had received neoadjuvant chemoradiotherapy, adjuvant therapy with nivolumab significantly improved disease-free survival compared to placebo.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Oncology

Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline

Manish A. Shah et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)